F8-KO

모델명

B6.129S-F8tm1Smoc

카탈로그

NM-KO-00012

모델 상태

Repository Live

PDF 받기

유전자 요약

Official Symbol
F8

모델 설명

F8-KO mice (Stock No.NM-KO-00012)carry a knockout allele derived from the targeted deletion of exon 16-19. While F8-KO(2) mice (Stock No.NM-KO-200608) carrying the exon 1-26 deletion.
신청분야:Hemophilia A;HEMA

Disease Connection

Factor Viii Deficiency

검증 데이터


微信截图_20220215125618.png

Fig 1. Schematic diagram for the F8 gene knockout mice generation strategy

4.png

Fig2. Analysis of activated partial thromboplastin time (APTT) in the F8 knock-out mice. The coagulation time in F8-KO mice (NM-KO-00012) was significantly longer than wild-type, and there was no obvious difference in coagulation time between F8-KO (NM-KO-00012) and F8-KO(2) (NM-KO-200608).


F8 gene knockout mice are an ideal animal model for studying the pathogenesis and drug screening of hemophilia A at the whole animal level. In addition, F8 gene knockout mice can provide an ideal animal model and a novel research tool for the screening and evaluation of hemophilia A drugs as well as the gene therapy of hemophilia A. F8 gene knockout mice provide an effective tool for further elucidating the pathogenesis of hemophilia A, for the evaluation and screening of drugs used for the prevention and treatment of hemophilia A, and for the development of new therapies.


당신은 또한 좋아할 수 있습니다

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

조회
Milestones

Our vision is to provide researchers all over the world with comprehensive, convenient and professional animal model services to facilitate a simplified and highly-efficient approach towards uncovering the mysteries of life.

조회